Lariocidin was efficient against strains of E. coli, including drug-resistant ones, according to the new study.

Researchers say they have discovered a new class of antibiotics that could treat drug-resistant bacteria, the first to reach the market in nearly three decades.

The new molecule, called lariocidin, works by targeting a part of a bacteria’s cell called the ribosome and can disrupt the cell’s functions.